These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21057966)

  • 1. Microglia activation is related to substantia nigra echogenicity.
    Berg D; Godau J; Riederer P; Gerlach M; Arzberger T
    J Neural Transm (Vienna); 2010 Nov; 117(11):1287-92. PubMed ID: 21057966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein.
    Walter U; Witt R; Wolters A; Wittstock M; Benecke R
    J Neural Transm (Vienna); 2012 Jan; 119(1):53-7. PubMed ID: 21626410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
    Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
    Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    Berg D
    J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
    Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
    J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
    Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
    Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
    Miwa H
    Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography.
    Becker G; Seufert J; Bogdahn U; Reichmann H; Reiners K
    Neurology; 1995 Jan; 45(1):182-4. PubMed ID: 7824114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
    Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
    J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.
    Berg D
    J Neural Transm (Vienna); 2011 Mar; 118(3):453-61. PubMed ID: 20830493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
    J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial sonography in the evaluation of Parkinson disease.
    Kolevski G; Petrov I; Petrova V
    J Ultrasound Med; 2007 Apr; 26(4):509-12. PubMed ID: 17384048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
    Fan Y; Ma J; Yang D; Li X; Liang K; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
    Eur J Neurosci; 2024 May; 59(10):2702-2714. PubMed ID: 38469656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.
    Berg D; Siefker C; Becker G
    J Neurol; 2001 Aug; 248(8):684-9. PubMed ID: 11569897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.